Platelet-Derived Growth Factor Receptor-α Subunit Targeting Suppresses Metastasis in Advanced Thyroid Cancer <i>In Vitro</i> and <i>In Vivo</i>.

Biomol Ther (Seoul) · 2021 · PMC8411021 · PMID 34031270

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may not be significantno p-value reported

The cell growth of MTT results revealed that imatinib had an IC50 of 16.7 μM in SW579 cells treated for 48 h, whereas imatinib had an IC50 of 21.9 μM in SW579 cells treated for 24 h, indicating that longer imatinib exposure has a better anti-cancer cell growth effect on SW579 cells, but the difference may not be significant.

also in 2,774 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.